LU63267A1 - - Google Patents

Info

Publication number
LU63267A1
LU63267A1 LU63267DA LU63267A1 LU 63267 A1 LU63267 A1 LU 63267A1 LU 63267D A LU63267D A LU 63267DA LU 63267 A1 LU63267 A1 LU 63267A1
Authority
LU
Luxembourg
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU63267A1 publication Critical patent/LU63267A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU63267D 1970-06-05 1971-06-02 LU63267A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702027645 DE2027645A1 (de) 1970-06-05 1970-06-05 Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU63267A1 true LU63267A1 (fr) 1972-08-23

Family

ID=5773104

Family Applications (1)

Application Number Title Priority Date Filing Date
LU63267D LU63267A1 (fr) 1970-06-05 1971-06-02

Country Status (10)

Country Link
US (1) US3984555A (fr)
AT (3) AT317899B (fr)
BE (1) BE768137A (fr)
CA (1) CA951319A (fr)
CH (3) CH569732A5 (fr)
DE (1) DE2027645A1 (fr)
FR (1) FR2100726B1 (fr)
GB (1) GB1331522A (fr)
LU (1) LU63267A1 (fr)
NL (1) NL7107695A (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US6723727B1 (en) * 1996-12-20 2004-04-20 Hoechst Aktiengesellschaft Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
EP0903344B1 (fr) * 1997-08-21 2011-01-26 Shiseido Co., Ltd. Dérivés de quinazolin-4-one, leur préparation et leur utilisation comme agents favorisant la croissance des cheveux ou dans une composition pour la peau à usage externe
US6355637B1 (en) 1999-10-01 2002-03-12 Advanced Medicine, Inc. Local anesthetic compounds
NZ522076A (en) * 2000-04-25 2005-08-26 Icos Corp Inhibitors of human phosphatidyl-inositol 3-kinase delta
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
US8349853B2 (en) 2001-09-05 2013-01-08 Minerva Biotechnologies Corporation Compositions and methods of treatment of cancer
JP2005501887A (ja) * 2001-09-05 2005-01-20 ミナーヴァ・バイオテクノロジーズ・コーポレーション 癌の処置における組成物およびその使用
US7060705B2 (en) 2001-11-07 2006-06-13 Merck & Co., Inc. Mitotic kinesin inhibitors
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
EP1558260A4 (fr) * 2002-11-04 2006-10-25 Nps Pharma Inc Composes de quinazolinone utilises comme calcilytiques
DE602004022819D1 (de) * 2003-06-06 2009-10-08 Vertex Pharma Von atp-bindende kassette transportern
US20050043239A1 (en) * 2003-08-14 2005-02-24 Jason Douangpanya Methods of inhibiting immune responses stimulated by an endogenous factor
US20050054614A1 (en) * 2003-08-14 2005-03-10 Diacovo Thomas G. Methods of inhibiting leukocyte accumulation
LT2612862T (lt) 2004-05-13 2017-01-25 Icos Corporation Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
WO2005117889A1 (fr) * 2004-05-25 2005-12-15 Icos Corporation Methodes de traitement et/ou de prevention de la proliferation aberrante des cellules hematopoietiques
CA2598409A1 (fr) * 2005-02-17 2006-08-24 Icos Corporation Procede d'inhibition d'accumulation de leucocytes
US8349850B2 (en) 2006-03-28 2013-01-08 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
JP5794919B2 (ja) 2008-11-13 2015-10-14 ギリアード カリストガ エルエルシー 血液学的な悪性疾患のための療法
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
CN102439012A (zh) 2009-03-24 2012-05-02 吉里德卡利斯托加公司 2-嘌呤基-3-甲苯基-喹唑啉酮衍生物的阻转异构体和使用方法
US8546409B2 (en) * 2009-04-20 2013-10-01 Gilead Calistoga Llc Methods of treatment for solid tumors
JP2013500257A (ja) 2009-07-21 2013-01-07 ギリアード カリストガ エルエルシー Ｐｉ３ｋインヒビターでの肝障害の処置
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
US9353067B2 (en) 2011-04-10 2016-05-31 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
CA2864305C (fr) 2012-03-05 2021-02-16 Gilead Calistoga Llc Formes polymorphes de l'acide -2-(1-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
AU2013288265B2 (en) 2012-07-09 2017-04-06 Lupin Limited Tetrahydroquinazolinone derivatives as PARP inhibitors
US9567337B2 (en) 2013-12-20 2017-02-14 Gilead Calistoga Llc Process methods for phosphatidylinositol 3-kinase inhibitors
WO2015095605A1 (fr) 2013-12-20 2015-06-25 Gilead Calistoga Llc Formes polymorphes d'un sel chlorhydrate de la (s)-2-(9h-purine-6-ylamino)propyl)-5-fluoro-3-phénylquinazolin-4(3h)-one
WO2015191726A1 (fr) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Inhibiteurs de la phosphatidylinositol 3-kinase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1053063A (fr) * 1963-05-18

Also Published As

Publication number Publication date
US3984555A (en) 1976-10-05
CH558374A (de) 1975-01-31
AT318628B (de) 1974-11-11
CH557829A (de) 1975-01-15
CH569732A5 (fr) 1975-11-28
FR2100726A1 (fr) 1972-03-24
AT318615B (de) 1974-11-11
FR2100726B1 (fr) 1975-10-10
CA951319A (en) 1974-07-16
NL7107695A (fr) 1971-12-07
AT317899B (de) 1974-09-25
GB1331522A (en) 1973-09-26
BE768137A (fr) 1971-12-06
DE2027645A1 (de) 1971-12-09

Similar Documents

Publication Publication Date Title
FR2100726B1 (fr)
AU1146470A (fr)
AU1473870A (fr)
AU1716970A (fr)
AU1336970A (fr)
AU1517670A (fr)
AU2130570A (fr)
AU1326870A (fr)
AU1689770A (fr)
AU1064870A (fr)
AU2119370A (fr)
AU1328670A (fr)
AU1603270A (fr)
AU1343870A (fr)
AU1277070A (fr)
AU1235770A (fr)
AU1247570A (fr)
AU2112570A (fr)
AU1083170A (fr)
AU1189670A (fr)
AU1591370A (fr)
AU2130770A (fr)
AU2115870A (fr)
AU2131570A (fr)
AU1581370A (fr)